Dr. Steven M. Bair, MD

Dr. Bair practices at UCHealth University of Colorado Hospital in Aurora, Colorado, part of UCHealth.

Dr. Bair's NPI, 1881014306, was assigned on April 23, 2014. Dr. Bair graduated from Clvlnd Clinic Lerner College of Med of Case Wstn Rsv University in 2014. Dr. Bair holds Colorado license DR.0064475.

Dr. Bair's primary practice is UCHealth University of Colorado Hospital, at 12605 E 16th Ave, Aurora, CO 80045 in Adams County. The practice phone is (720) 848-0000.

Dr. Bair's primary practice is UCHealth University of Colorado Hospital in Aurora, Colorado, part of UCHealth. Dr. Bair is also affiliated with Children's Hospital Colorado Anschutz Medical Campus. The medical group on file is University of Colorado Medicine (CU Medicine). Dmand AI also links Dr. Bair to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bair practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Bair's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Bair's licenses on file in 2 states: Colorado and Pennsylvania.

CMS data shows 484 Medicare services from Dr. Bair across 5 procedure codes in 2024, for 159 Medicare patients. Medicare paid $41,970 for them.

CMS counts 159 Medicare patients who saw Dr. Bair in 2024. The largest group is 65 to 74, with 80 patients. 66% of them have high blood pressure, and 58% have high cholesterol. 12% are also on Medicaid. Their average risk score is 2.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bair's median patient age at 72, with 40% women.

In 2024, Dr. Bair wrote 442 Medicare Part D claims for 55 patients. 60% of them were for generic drugs. CMS names the drug for 317 of them, across 11 drugs with 11 or more claims each, at $2,245,696 in total drug cost. In 2023, CMS named 102 claims across 4 drugs.

Dr. Bair accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bair as offering telehealth.

Dmand AI links 17 papers to Dr. Bair, published from 2017 to 2025. 2020 was the busiest year, with 4. The most frequent topics are Hodgkin Disease, Antineoplastic Agents, Immunological and Antineoplastic Combined Chemotherapy Protocols. Dr. Bair has published most often in Blood Adv. Dr. Bair's most frequent co-authors are Jakub Svoboda, MD, Daniel J. Landsburg, MD and Philippe Armand, MD, PhD.

Dmand AI links Dr. Bair to 2 clinical trials. 2 are still active or recruiting. Conditions studied include Hodgkin Disease and Lymphoma.

CMS Open Payments shows 13 general payments to Dr. Bair from 7 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 88% of the total. Abbvie Inc. paid the most, $1,737.

Dr. Bair graduated from Clvlnd Clinic Lerner College of Med of Case Wstn Rsv University in 2014.